Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma Academic Article uri icon

Overview

MeSH Major

  • Carcinoma, Hepatocellular
  • Liver Neoplasms
  • Radiosurgery

abstract

  • SBRT is effective therapy for patients with HCC with an overall best response rate (CR + PR) of 73%. Nonenhancement on imaging, a surrogate for ablation, may be a more useful indicator than size reduction in evaluating HCC response to SBRT in the first 6 to 12 months, supporting EASL criteria.

publication date

  • June 15, 2012

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.26404

PubMed ID

  • 22025126

Additional Document Info

start page

  • 3191

end page

  • 8

volume

  • 118

number

  • 12